The International Working Group on Signal Detection and Management in Pharmacovigilance
The International Working Group (IWG) on Signal Detection and Management in Pharmacovigilance was launched in March 2019. Experts from over 20 organisations in the pharma industry and academia have joined the IWG in order to examine aspects of signal detection and signal management. A list of members of the IWG is available here.
Signal Detection and Management are key steps in the pharmacovigilance process. While the CIOMS Working Group Report on Signal Detection was published in 2010, a lot has happened in this field since then. IWG members include international experts in signal detection who will examine the science, define the needs and propose ideas and guidance for the future.
The IWG on Signal Detection and Management in Pharmacovigilance is managed under the auspices of the DSRU Centre for Pharmacovigilance Methodology, which was created in 2018 to undertake methodological work to improve and enhance pharmacovigilance.
The IWG is expected to run for 3 years.
The mission of the IWG is to assess the impact of new developments in biomedical sciences on signal detection and management in pharmacovigilance, aiming to improve its efficiency and protect public health.
The objectives of the IWG can be downloaded here.
Eleven subgroups will be established in order to address each of the key issues. Each subgroup will contribute a chapter to a final report, which will be published in 2022.
Watch this short video for further information about the IWG on Signal Detection and Management in Pharmacovigilance: